Related Experiment Video
Updated: Aug 12, 2026

Chronic Salmonella Infected Mouse Model
Published on: May 31, 2010
Quinolones and Salmonella septic arthritis
Piroon Mootsikapun1, Ajanee Mahakkanukrauh, Siraphop Suwannaroj
1Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Abstract:
Salmonella septic arthritis is an infrequent infectious disease but can cause progressive joint destruction resulting in disability. The authors retrospectively reviewed cases with culture proved Salmonella septic arthritis in Srinagarind Hospital, Khon Kaen from 1994 to 2000. There were 23 episodes in 16 cases; all had underlying diseases and a history of steroid abuse or steroid and immunosuppressive therapy. Systemic lupus erythematosus was the most commonly found underlying disease (56%). Salmonella group D and group B were isolated in 13 and 3 cases. Most first episodes had acute onset of monoarthritis. The antibiotics used as initial treatment of the first episodes were beta lactam, cotrimoxazole or quinolones. There were 8 cases with disabled sequelae and 7 cases with relapse. For 13 evaluable first episodes, relapse occurred in 3 cases in the cephalosporin/penicillin and 4 cases in the cotrimoxazole treated group but none in the quinolones. Six relapse cases were treated successfully with quinolones as well as one with cotrimoxazole. Although 5 relapse cases treated with quinolones had previous progressive joint destruction or avascular necrosis, there was no further joint damage after re-treatment with quinolones. In conclusion, quinolones were more effective than beta-lactams and cotrimoxazole for the treatment of Salmonella septic arthritis to prevent relapse and progressive joint destruction.
Insights
Quinolone antibiotics are more effective in treating Salmonella septic arthritis, preventing relapses and further joint damage compared to beta-lactams and cotrimoxazole. This finding is crucial for managing this rare but debilitating infectious disease.
Area of Science:
- Infectious Diseases
- Rheumatology
- Pharmacology
Background:
- Salmonella septic arthritis is a rare infectious disease that can lead to severe joint destruction and disability.
- Patients often have underlying conditions, such as systemic lupus erythematosus, and a history of steroid or immunosuppressive therapy.
Purpose of the Study:
- To evaluate the effectiveness of different antibiotic treatments for Salmonella septic arthritis.
- To compare the relapse rates and joint destruction outcomes associated with various antibiotic regimens.
Main Methods:
- Retrospective review of 23 episodes of culture-proven Salmonella septic arthritis in 16 patients from 1994 to 2000.
- Analysis of underlying diseases, initial antibiotic treatments (beta-lactam, cotrimoxazole, quinolones), relapse rates, and long-term sequelae.
Main Results:
- Quinolones showed no relapses in initial treatment, while beta-lactams/penicillins had 3 and cotrimoxazole had 4 relapses.
- Quinolones were successful in treating 6 relapsed cases, preventing further joint damage even in patients with pre-existing destruction.
- Systemic lupus erythematosus was the most common underlying disease (56%).
Conclusions:
- Quinolones are more effective than beta-lactams and cotrimoxazole in treating Salmonella septic arthritis.
- Quinolone therapy helps prevent disease relapse and progressive joint destruction, improving patient outcomes.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Gene Regulation in Microbial Communities: Quorum Sensing
Reservoir of Infection
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial DNA Synthesis
Clinical Significance of Antibiotic Resistance

